Search research articles
Contact Us
Filters
Showing results (81-90 of 109) with videos related to
Page
of 11
Sort By:
American Heart Journal
|
December 3, 2014
Rationale and design for PACE: patients with intermittent claudication injected with ALDH bright cells
Emerson C Perin, Michael Murphy, John P Cooke, et al.
Journal of the American College of Cardiology
|
March 1, 2023
Randomized Trial of Targeted Transendocardial Mesenchymal Precursor Cell Therapy in Patients With Heart Failure
Emerson C Perin, Kenneth M Borow, Timothy D Henry, et al.
American Heart Journal
|
June 23, 2014
Adipose-derived regenerative cells in patients with ischemic cardiomyopathy: The PRECISE Trial
Emerson C Perin, Ricardo Sanz-Ruiz, Pedro L Sánchez, et al.
Circulation
|
January 12, 2005
Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model
Guilherme V Silva, Silvio Litovsky, Joao A R Assad, et al.
Cardiovascular Research
|
August 13, 2021
Recommendations for nomenclature and definition of cell products intended for human cardiovascular use
Doris A Taylor, Lourdes Chacon-Alberty, Luiz C Sampaio, et al.
Texas Heart Institute Journal
|
November 26, 2004
Catheter-based transendocardial delivery of autologous bone-marrow-derived mononuclear cells in patients listed for heart transplantation
Guilherme V Silva, Emerson C Perin, Hans F R Dohmann, et al.
ESC Heart Failure
|
March 2, 2021
Reparative cell therapy for the heart: critical internal appraisal of the field in response to recent controversies
Thomas J Povsic, Ricardo Sanz-Ruiz, Andreu M Climent, et al.
Circulation
|
September 15, 2004
Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy
Emerson C Perin, Hans F R Dohmann, Radovan Borojevic, et al.
Circulation
|
April 17, 2013
Phase II clinical research design in cardiology: learning the right lessons too well: observations and recommendations from the Cardiovascular Cell Therapy Research Network (CCTRN)
Joshua M Hare, Roberto Bolli, John P Cooke, et al.
American Heart Journal
|
June 19, 2018
Rationale and Design of the SENECA (StEm cell iNjECtion in cAncer survivors) Trial
Roberto Bolli, Joshua M Hare, Timothy D Henry, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 109) with videos related to
Sort By:
Page
of 11
American Heart Journal
|
December 3, 2014
Rationale and design for PACE: patients with intermittent claudication injected with ALDH bright cells
Emerson C Perin, Michael Murphy, John P Cooke, et al.
Journal of the American College of Cardiology
|
March 1, 2023
Randomized Trial of Targeted Transendocardial Mesenchymal Precursor Cell Therapy in Patients With Heart Failure
Emerson C Perin, Kenneth M Borow, Timothy D Henry, et al.
American Heart Journal
|
June 23, 2014
Adipose-derived regenerative cells in patients with ischemic cardiomyopathy: The PRECISE Trial
Emerson C Perin, Ricardo Sanz-Ruiz, Pedro L Sánchez, et al.
Circulation
|
January 12, 2005
Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model
Guilherme V Silva, Silvio Litovsky, Joao A R Assad, et al.
Cardiovascular Research
|
August 13, 2021
Recommendations for nomenclature and definition of cell products intended for human cardiovascular use
Doris A Taylor, Lourdes Chacon-Alberty, Luiz C Sampaio, et al.
Texas Heart Institute Journal
|
November 26, 2004
Catheter-based transendocardial delivery of autologous bone-marrow-derived mononuclear cells in patients listed for heart transplantation
Guilherme V Silva, Emerson C Perin, Hans F R Dohmann, et al.
ESC Heart Failure
|
March 2, 2021
Reparative cell therapy for the heart: critical internal appraisal of the field in response to recent controversies
Thomas J Povsic, Ricardo Sanz-Ruiz, Andreu M Climent, et al.
Circulation
|
September 15, 2004
Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy
Emerson C Perin, Hans F R Dohmann, Radovan Borojevic, et al.
Circulation
|
April 17, 2013
Phase II clinical research design in cardiology: learning the right lessons too well: observations and recommendations from the Cardiovascular Cell Therapy Research Network (CCTRN)
Joshua M Hare, Roberto Bolli, John P Cooke, et al.
American Heart Journal
|
June 19, 2018
Rationale and Design of the SENECA (StEm cell iNjECtion in cAncer survivors) Trial
Roberto Bolli, Joshua M Hare, Timothy D Henry, et al.
Page
of 11